Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) fell 11.6% on Tuesday. The company traded as low as GBX 9 and last traded at GBX 9.50. 747,032 shares changed hands during trading, an increase of 216% from the average daily volume of 236,039 shares. The stock had previously closed at GBX 10.75.
Abingdon Health Price Performance
The stock has a market cap of £24.01 million, a P/E ratio of -11.73 and a beta of 0.13. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The firm has a 50-day moving average price of GBX 10.77 and a 200-day moving average price of GBX 10.51.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Featured Articles
- Five stocks we like better than Abingdon Health
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
